Form D — Stipple Bio, Inc.
0001932776-26-000002 · filed Apr 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $100,200,007
- Reported amount sold
- $65,130,013
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Stipple Bio, Inc.
- CIK
- 1932776
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 238 Main Street
Cambridge, Massachusetts 02142 - Phone
- (646) 248-0890
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jeffrey Landau · Executive OfficerCambridge, Massachusetts Find on LinkedIn ↗
-
Vineeta Agarwala · DirectorMenlo Park, California Find on LinkedIn ↗
-
Owen Hughes · DirectorSudbury, Massachusetts Find on LinkedIn ↗
-
Greg Verdine · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
Aaron Ring · DirectorCambridge, Massachusetts Find on LinkedIn ↗
-
Derek DiRocco · DirectorBoston, Massachusetts Find on LinkedIn ↗
-
Thilo Schroeder · DirectorGrand Duchy of Luxembourg, Luxembourg Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗